000			01525 a2200433 4500
005			20250513165149.0
264		0	_c19990712
008			199907s 0 0 eng d
022			_a0887-4476
024	7		_a10.1002/(SICI)1098-2396(199902)31:2<119::AID-SYN4>3.0.CO;2-O _2doi
040			_aNLM _beng _cNLM
100	1		_aRinne, J O
245	0	0	_aStriatal uptake of a novel PET ligand, [18F]beta-CFT, is reduced in early Parkinson's disease. _h[electronic resource]
260			_bSynapse (New York, N.Y.) _cFeb 1999
300			_a119-24 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAnimals
650	0	4	_aCaudate Nucleus _xdiagnostic imaging
650	0	4	_aCocaine _xanalogs & derivatives
650	0	4	_aDopamine Uptake Inhibitors _xpharmacokinetics
650	0	4	_aFemale
650	0	4	_aFluorine Radioisotopes _xpharmacokinetics
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aParkinson Disease _xdiagnostic imaging
650	0	4	_aPutamen _xdiagnostic imaging
650	0	4	_aTomography, Emission-Computed
700	1		_aBergman, J
700	1		_aRuottinen, H
700	1		_aHaaparanta, M
700	1		_aEronen, E
700	1		_aOikonen, V
700	1		_aSonninen, P
700	1		_aSolin, O
773	0		_tSynapse (New York, N.Y.) _gvol. 31 _gno. 2 _gp. 119-24
856	4	0	_uhttps://doi.org/10.1002/(SICI)1098-2396(199902)31:2<119::AID-SYN4>3.0.CO;2-O _zAvailable from publisher's website
999			_c9985365 _d9985365